Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [1] Comparison of the degenerative and inflammatory markers in cerebrospinal fluid in multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome
    Sladkova, V.
    Mares, J.
    Lubenova, B.
    Zapletalova, J.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2009, 256 : S89 - S89
  • [2] Comparison of the degenerative and inflammatory markers in cerebrospinal fluid in multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome
    Sladkova, V.
    Mares, J.
    Novakova, B.
    Kollarova, K.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 147 - 147
  • [3] Comparison of the degenerative and inflammatory markers in cerebrospinal fluid in multiple sclerosis patients with relapsing-remitting course of disease and after clinically isolated syndrome
    Sladkova, Vladimira
    Mares, Jan
    Lubenova, Blanka
    Kollarova, Katarina
    Kanovsky, Petr
    MULTIPLE SCLEROSIS, 2008, 14 : S287 - S288
  • [4] Cerebrospinal fluid proteome profile in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Tumani, Hayrettin
    Rau, Daniela
    Palm, Christian
    Brettschneider, Johannes
    Suessmuth, Sigurd
    Lehmensiek, Vera
    MULTIPLE SCLEROSIS, 2008, 14 : S290 - S290
  • [5] Markers of neuronal and glial damage in serum and cerebrospinal fluid of patients with Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome
    Boziki, Marina
    Chatziefstathiou, Athanasia
    Konstantinidou, Natalia
    Bakirtzis, Christos
    Kesidou, Evangelia
    Sintila, Stiliani-Angeliki
    Theotokis, Paschalis
    Canaslan, Sezgi
    Schmitz, Matthias
    Zerr, Inga
    Dafou, Dimitra
    Sklaviadis, Theodoros
    Grigoriadis, Nikolaos
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 895 - 896
  • [6] Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Pavelek, Zbysek
    Vysata, Oldrich
    Tambor, Vojtech
    Pimkova, Kristyna
    Dai Long Vu
    Kuca, Kamil
    Stourac, Pavel
    Valis, Martin
    BIOMEDICAL REPORTS, 2016, 5 (01) : 35 - 40
  • [7] Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Evangelopoulos, Maria-Eleftheria
    Koutsis, Georgios
    Boufidou, Fotini
    Markianos, Manolis
    NEUROBIOLOGY OF DISEASE, 2022, 174
  • [8] Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis
    Greco, A
    Minghetti, L
    Puopolo, M
    Cannoni, S
    Romano, S
    Pozzilli, C
    Levi, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 224 (1-2) : 23 - 27
  • [9] Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Hakansson, I.
    Tisell, A.
    Cassel, P.
    Blennow, K.
    Zetterberg, H.
    Lundberg, P.
    Dahle, C.
    Vrethem, M.
    Ernerudh, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (05) : 703 - 712
  • [10] Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
    Moreira, MA
    Souza, ALS
    Lana-Peixoto, MA
    Teixeira, MM
    Teixeira, AL
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (04) : 441 - 445